| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 临床阶段(元) | 799,447,873.63 | 1,507,098,338.18 | 859,341,319.75 | 1,666,325,421.25 | 967,786,080.96 |
| 新兴服务(元) | 499,946,931.26 | 1,199,333,374.24 | 530,554,265.03 | 995,919,771.12 | 393,322,245.57 |
| 商业化阶段(元) | 1,395,943,785.47 | 5,112,480,745.14 | 3,227,329,697.34 | 7,586,807,240.02 | 3,675,840,964.99 |
| 其他(元) | - | 6,277,840.71 | 4,285,097.32 | 6,272,960.43 | 4,300,884.95 |
| 营业成本(元) | |||||
| 临床阶段(元) | 467,054,341.87 | 893,098,773.91 | 493,840,134.49 | 978,386,888.02 | 537,311,630.18 |
| 新兴服务(元) | 398,532,323.57 | 881,726,631.79 | 351,535,397.97 | 660,477,362.56 | 225,103,751.84 |
| 商业化阶段(元) | 692,266,703.95 | 2,041,367,918.54 | 1,319,523,355.56 | 3,752,539,786.68 | 1,904,124,022.25 |
| 其他(元) | - | 5,606,968.81 | 4,123,945.15 | 6,194,077.41 | -260,901.81 |
| 毛利(元) | |||||
| 临床阶段(元) | 332,393,531.76 | 613,999,564.27 | 365,501,185.26 | 687,938,533.23 | 430,474,450.78 |
| 新兴服务(元) | 101,414,607.69 | 317,606,742.45 | 179,018,867.06 | 335,442,408.56 | 168,218,493.73 |
| 商业化阶段(元) | 703,677,081.52 | 3,071,112,826.60 | 1,907,806,341.78 | 3,834,267,453.34 | 1,771,716,942.74 |
| 其他(元) | - | 670,871.90 | 161,152.17 | 78,883.02 | 4,561,786.76 |
| 毛利率(%) | |||||
| 临床阶段(%) | 41.58 | 40.74 | 42.53 | 41.28 | 44.48 |
| 新兴服务(%) | 20.29 | 26.48 | 33.74 | 33.68 | 42.77 |
| 商业化阶段(%) | 50.41 | 60.07 | 59.11 | 50.54 | 48.20 |
| 其他(%) | - | 10.69 | 3.76 | 1.26 | 106.07 |
| 收入构成(%) | |||||
| 临床阶段(%) | 29.66 | 19.26 | 18.59 | 16.25 | 19.20 |
| 新兴服务(%) | 18.55 | 15.33 | 11.48 | 9.71 | 7.80 |
| 商业化阶段(%) | 51.79 | 65.33 | 69.83 | 73.98 | 72.92 |
| 其他(%) | - | 0.08 | 0.09 | 0.06 | 0.09 |
| 毛利构成(%) | |||||
| 临床阶段(%) | 29.22 | 15.34 | 14.90 | 14.16 | 18.13 |
| 新兴服务(%) | 8.92 | 7.93 | 7.30 | 6.91 | 7.08 |
| 商业化阶段(%) | 61.86 | 76.71 | 77.79 | 78.93 | 74.60 |
| 其他(%) | - | 0.02 | 0.01 | 0.00 | 0.19 |